Can trazodone be used for anxiety and depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Trazodone Be Used for Anxiety and Depression?

Yes, trazodone is FDA-approved for major depressive disorder in adults and has demonstrated efficacy for both depression and anxiety symptoms, making it an appropriate treatment option for these conditions. 1

FDA-Approved Indication

  • Trazodone is officially indicated for the treatment of major depressive disorder (MDD) in adults 1
  • The FDA approval is based on established efficacy from inpatient and outpatient trials demonstrating effectiveness in treating depression 1

Efficacy for Depression

  • Trazodone demonstrates comparable antidepressant efficacy to other second-generation antidepressants, including SSRIs 2
  • Clinical studies show significant improvement in Hamilton Depression Scale scores, with normalization occurring within 6 weeks of treatment 3
  • In comparative trials, trazodone showed similar efficacy to fluoxetine, paroxetine, and venlafaxine for maintaining response or remission of MDD 2
  • Response rates indicate that one-third of inpatients and one-half of outpatients achieve significant therapeutic response by the end of the first week, with remaining patients responding within 2-4 weeks 4

Efficacy for Anxiety

  • Trazodone is effective for treating anxiety symptoms that accompany depression 5, 3
  • Clinical trials demonstrate no significant difference between trazodone and other second-generation antidepressants (fluoxetine, paroxetine, sertraline) for treating anxiety associated with MDD 2
  • Patient self-ratings using the Zung Self-Rating Anxiety Scale show significant improvement by week 2 and week 6 of therapy 3
  • The anxiolytic properties make it particularly useful for patients with comorbid anxiety and depression 6, 7

Dosing and Administration

  • Initial dosing: Start at 50 mg twice daily or 150 mg once daily for the controlled-release formulation 4, 3
  • Therapeutic range: 150-300 mg/day for most patients in outpatient settings 8
  • Maximum dosing: Up to 400 mg/day in outpatients; hospitalized patients may receive up to 600 mg/day under close monitoring 4
  • Administration: Take shortly after a meal or light snack to optimize absorption and reduce side effects 1
  • Titration: Allow 1-2 weeks between dose adjustments due to the medication's long half-life 2

Advantages Over Other Antidepressants

  • Trazodone avoids the side effects of insomnia, anxiety, and sexual dysfunction commonly associated with SSRIs 8
  • It has minimal anticholinergic activity compared to tricyclic antidepressants, making it better tolerated in elderly patients 2, 7
  • The medication is relatively safe in overdose compared to older tricyclic antidepressants 7
  • Trazodone has a rapid onset of action with low liability for activating side effects 8

Common Side Effects to Monitor

  • Most common: Drowsiness/somnolence (most frequently reported), followed by dizziness, dry mouth, headache, and nervousness 1, 4, 8
  • Cardiovascular: Orthostatic hypotension (especially in elderly or those with cardiovascular disease), QT prolongation, and cardiac arrhythmias 7, 8
  • Rare but serious: Priapism (requires immediate medical attention) 7, 8
  • Side effect incidence decreases over time: 16.9% of patients report side effects at week 2, dropping to 7.6% by week 6 3

Important Clinical Considerations

  • Contraindications: Do not use with MAOIs or within 2 weeks of MAOI discontinuation 1
  • Drug interactions: Exercise caution with triptans, other serotonergic agents, warfarin, phenytoin, and CYP3A4 inhibitors 1
  • Special populations: Dosage adjustments may be needed in elderly patients, those with hepatic or renal impairment, and patients with cardiovascular disease 1, 7
  • Pregnancy/breastfeeding: Trazodone passes into breast milk; discuss risks and benefits with patients 1

Common Pitfalls to Avoid

  • Inadequate dosing: Many providers use subtherapeutic doses (50-100 mg) appropriate only for insomnia rather than antidepressant doses of 150-300 mg/day 8
  • Premature discontinuation: Allow 4-6 weeks at therapeutic doses before determining efficacy, as full response may take this long 4, 3
  • Abrupt discontinuation: Never stop trazodone suddenly without tapering over 10-14 days to limit withdrawal symptoms 2, 1
  • Ignoring cardiovascular risk: Monitor for orthostatic hypotension, especially in elderly patients and those with pre-existing heart disease 7, 8
  • Missing drug interactions: Always review concomitant medications, particularly other serotonergic agents and CYP3A4 inhibitors/inducers 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.